Objective: To observe the clinical efficacy of multiple sclerosis (MS) treated with electroacupuncture and acupoint injection.
Methods: The block randomization method was used to divide 40 cases into an electroacupuncture (EA) group and an EA + acupoint injection (AI) group, 20 cases in each one. In the EA group, EA was used at corresponding Jiaji (EX-B 2), Weizhong (BL 40), Chengshan (BL 57), etc. In the EA + AI group, on the basis of EA, the acupoint injection of mouse nerve growth factor was supplemented. The activity of daily life (ADL) and expanded disability status score (EDSS) were observed in the two groups before and after treatment for the evaluation of the efficacy.
Results: The efficacy was achieved on MS after treatment in both groups (P < 0.01). After treatment, the scores of EDSS and Barthel index were (3.01 +/- 1.31) and (83.11 +/- 8.45) in the EA + AI group, which were better than those of (4.23 +/- 1.21) and (75.25 +/- 6.25) in the EA group (both P < 0.01).
Conclusion: EA and AI co-act on reducing disability and improving the life quality in the treatment of MS and have achieved coordinately the significant effects.